Modulating TNF-α signaling with natural products

Drug Discovery Today - Tập 11 - Trang 725-732 - 2006
Atish T. Paul1, Vikrantsinh M. Gohil1, Kamlesh K. Bhutani1
1Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S.A.S. Nagar, Punjab 160062, India

Tài liệu tham khảo

Carswell, 1975, An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Natl. Acad. Sci. U. S. A., 72, 3666, 10.1073/pnas.72.9.3666 Wiemann, 1994, Coley's toxins, tumor necrosis factor and cancer research: a historical perspective, Pharmacol. Ther., 64, 529, 10.1016/0163-7258(94)90023-X Perez, 1990, A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact, Cell, 63, 251, 10.1016/0092-8674(90)90158-B Jones, 1989, Structure of tumour necrosis factor, Nature, 338, 225, 10.1038/338225a0 Meager, 1991 Hotamisligil, 1994, Tumor necrosis factor alpha inhibits signaling from the insulin receptor, Proc. Natl. Acad. Sci. U. S. A., 91, 4854, 10.1073/pnas.91.11.4854 Pober, 1987, Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species, J. Immunol., 138, 3319, 10.4049/jimmunol.138.10.3319 Slowik, 1993, Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration, Am. J. Pathol., 143, 1724 Jirik, 1989, Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells, J. Immunol., 142, 144, 10.4049/jimmunol.142.1.144 Nawroth, 1986, Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1, J. Exp. Med., 163, 1363, 10.1084/jem.163.6.1363 Nawroth, 1988, Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas, J. Exp. Med., 168, 637, 10.1084/jem.168.2.637 Nawroth, 1986, Modulation of endothelial cell hemostatic properties by tumor necrosis factor, J. Exp. Med., 163, 740, 10.1084/jem.163.3.740 Estrada, 1992, Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells, Biochem. Biophys. Res. Commun., 186, 475, 10.1016/S0006-291X(05)80832-0 Yoshizumi, 1993, Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life, Circ. Res., 73, 205, 10.1161/01.RES.73.1.205 Brett, 1989, Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins, J. Exp. Med., 169, 1977, 10.1084/jem.169.6.1977 Goldblum, 1990, Tumor necrosis factor-alpha augments pulmonary arterial transendothelial albumin flux in vitro, Am. J. Physiol., 258, L57 Tracey, 1994, Tumor necrosis factor: a pleiotropic cytokine and therapeutic target, Annu. Rev. Med., 45, 491, 10.1146/annurev.med.45.1.491 Palladino, 2003, Anti-TNF-alpha therapies: the next generation, Nat. Rev. Drug Discov., 2, 736, 10.1038/nrd1175 Herath, 2003, Inhibitory effect of some flavonoids on tumor necrosis factor-alpha production in lipopolysaccharide-stimulated mouse macrophage cell line J774.1, J. Med. Food, 6, 365, 10.1089/109662003772519930 Xagorari, 2001, Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages, J. Pharmacol. Exp. Ther., 296, 181 Bi, 2005, Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia, Int. Immunopharmacol., 5, 185, 10.1016/j.intimp.2004.08.008 Cho, 2000, Inhibitor of tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW264.7 cells from Amorpha fruticosa, J. Ethnopharmacol., 70, 127, 10.1016/S0378-8741(99)00154-3 Fang, 2005, Inhibitory effects of flavonol glycosides from Cinnamomum osmophloeum on inflammatory mediators in LPS/IFN-gamma-activated murine macrophages, Bioorg. Med. Chem., 13, 2381, 10.1016/j.bmc.2005.01.050 Kim, 2004, Scopoletin suppresses pro-inflammatory cytokines and PGE2 from LPS-stimulated cell line, RAW 264.7 cells, Fitoterapia, 75, 261, 10.1016/j.fitote.2003.12.021 Chan, 1995, Inhibition of tumor necrosis factor by curcumin, a phytochemical, Biochem. Pharmacol., 49, 1551, 10.1016/0006-2952(95)00171-U Hashimoto, 2003, Isolation and synthesis of TNF-alpha release inhibitors from Fijian kawa (Piper methysticum), Phytomedicine, 10, 309, 10.1078/094471103322004802 Jeong, 2002, Inhibition of TNF-alpha and IL-6 production by Aucubin through blockade of NF-kappaB activation RBL-2H3 mast cells, Cytokine, 18, 252, 10.1006/cyto.2002.0894 Ju, 2003, Inhibitory effects of nardostachin on nitric oxide, prostaglandin E2, and tumor necrosis factor-alpha production in lipopolysaccharide activated macrophages, Biol. Pharm. Bull., 26, 1375, 10.1248/bpb.26.1375 Ryu, 2002, Two neolignans from Perilla frutescens and their inhibition of nitric oxide synthase and tumor necrosis factor-alpha expression in murine macrophage cell line RAW 264.7, Bioorg. Med. Chem. Lett., 12, 649, 10.1016/S0960-894X(01)00812-5 Tse, 2005, Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation, Biochem. Pharmacol., 70, 1443, 10.1016/j.bcp.2005.08.011 Posadas, 2003, Inhibition of the NF-kappaB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M, Biochem. Pharmacol., 65, 887, 10.1016/S0006-2952(02)01659-3 Wadsworth, 2001, Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha, Biochem. Pharmacol., 62, 963, 10.1016/S0006-2952(01)00734-1 Yui, 2001, Inhibition effect of amaryllidaceae alkaloids, lycorine and lycoricidinol on macrophage TNF- α production, Yakugaku Zasshi, 121, 167, 10.1248/yakushi.121.167 Takahashi, 2003, Abietic acid activates peroxisome proliferator-activated receptor-gamma (PPARgamma) in RAW264.7 macrophages and 3T3-L1 adipocytes to regulate gene expression involved in inflammation and lipid metabolism, FEBS Lett., 550, 190, 10.1016/S0014-5793(03)00859-7 Kang, 1996, Suppression of interleukin-1 and tumor necrosis factor-alpha production by acanthoic acid, (−)-pimara-9(11),15-dien-19-oic acid, and it antifibrotic effects in vivo, Cell. Immunol., 170, 212, 10.1006/cimm.1996.0154 Kim, 2001, Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-kappaB activation, Biochem. Pharmacol., 61, 903, 10.1016/S0006-2952(01)00538-X Jang, 2003, Tanshinone IIA from Salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-alpha, IL-1beta and IL-6 in activated RAW 264.7 cells, Planta Med., 69, 1057, 10.1055/s-2003-45157 Murakami, 2005, New class of linoleic acid metabolites biosynthesized by corn and rice lipoxygenases: suppression of proinflammatory mediator expression via attenuation of MAPK- and Akt-, but not PPARgamma-, dependent pathways in stimulated macrophages, Biochem. Pharmacol., 70, 1330, 10.1016/j.bcp.2005.07.032 Manjula, 2006, Inhibition of MAP kinases by crude extract and pure compound isolated from Commiphora mukul leads to down regulation of TNF-alpha, IL-1beta and IL-2, Int. Immunopharmacol., 6, 122, 10.1016/j.intimp.2005.07.001 Dheen, 2005, Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia, Glia, 50, 21, 10.1002/glia.20153